Tarsons Products peers

Companies like Tarsons Productslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TARSONS₹303.95

Tarsons Products Limited

· Pharma & Health
₹ CrorePeersFISCHERLAXMIDENTLFABTECHGKBMcap ₹1,617 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
TARSONS
FY26
FISCHER
FY26
LAXMIDENTL
FY26
FABTECH
FY26
Peer
Average
Valuation — at last close
P/E112.99×54.02×32.07×◆ 12.22×32.77× +245%
P/B2.55×4.42×4.01×◆ 1.29×3.24× -21%
EV/EBITDA16.74×40.51×21.97×◆ 10.50×24.33× -31%
Market Cap₹1,617 Cr₹1,697 Cr₹975 Cr₹543 Cr₹1,072 Cr +51%
Growth
Revenue YoY (latest Q)20.66%◆ 249.42%13.87%-24.20%79.70% -74%
Net Income YoY (latest Q)-180.99%-24.30%◆ 23.83%-46.54%-15.67% -1055%
Profitability
EBITDA Margin◆ 27.91%13.96%15.62%8.52%12.70% +120%
Net Income Margin3.39%10.05%◆ 10.41%9.34%9.93% -66%
Return on Common Equity2.26%8.07%◆ 12.83%9.14%10.01% -77%
Return on Capital Employed2.34%9.71%◆ 11.21%6.65%9.19% -75%
Return on Assets1.26%4.62%◆ 9.99%5.87%6.83% -82%
Credit & Quality
Total Debt/Equity0.60×0.19×◆ 0.00×0.10×0.10× +521%
Interest Coverage0.95×6.87×◆ 20.15×7.14×11.39× -92%
Scale — latest FY
Revenue / Total Income₹423 Cr₹309 Cr₹278 Cr₹411 Cr₹332 Cr +27%
Net Income₹14.3 Cr₹31 Cr₹28.9 Cr₹38.4 Cr₹32.8 Cr -56%
Total Assets₹1,186 Cr₹671 Cr₹294 Cr₹654 Cr₹540 Cr +120%
EPS₹2.69₹0.48₹5.53₹10₹5.34 -50%
Book Value per Share₹119.29₹5.87₹44.27₹94.43₹48.19 +148%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.